Insider · CIK 0001500189

EASTLAND JULIA MARIE

Reports to the SEC for 6 companies · BEDFORD, MA

sec.gov

Transactions

Companies

Filings

CIK

0001500189

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-14	LNTHLantheus Holdings, Inc.A Award	Director	AAward	+4,137 sh	—	—	8,019
2026-02-09	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Director, CEO & President	SSale	−889 sh	$2.39	−$2,127.288	79,133
2026-02-06	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Director, CEO & President	SSale	−7,866 sh	$2.43	−$19.1K	80,022
2026-01-08	ZNTLZentalis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, CEO & President	AAward	+775K sh	—	—	775,000
2025-05-14	LNTHLantheus Holdings, Inc.A Award	Director	AAward	+2,537 sh	—	—	3,882
2025-05-14	LNTHLantheus Holdings, Inc. · Stock Option (right to buy)A Award	Director	AAward	+4,543 sh	—	—	4,543
2025-02-03	ZNTLZentalis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, CEO & President	AAward	+59.4K sh	—	—	59,388
2025-02-03	ZNTLZentalis Pharmaceuticals, Inc.A Award	Director, CEO & President	AAward	+59.4K sh	—	—	87,888
2025-01-31	ZNTLZentalis Pharmaceuticals, Inc.P Purchase	Director, CEO & President	PPurchase	+28.5K sh	$1.73	+$49.3K	28,500
2024-12-02	ZNTLZentalis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, CEO & President	AAward	+3.03M sh	—	—	3,028,800
2024-09-10	LNTHLantheus Holdings, Inc.A Award	Director	AAward	+1,345 sh	—	—	1,345
2024-09-10	LNTHLantheus Holdings, Inc. · Stock Option (right to buy)A Award	Director	AAward	+2,506 sh	—	—	2,506
2024-05-23	DVAXDYNAVAX TECHNOLOGIES CORP · Stock Option (Right to Buy)A Award	Director	AAward	+22.5K sh	—	—	22,500
2024-05-23	DVAXDYNAVAX TECHNOLOGIES CORPA Award	Director	AAward	+5,357 sh	—	—	16,071
2024-03-11	Harpoon Therapeutics, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−40.8K sh	—	—	0
2024-03-11	Harpoon Therapeutics, Inc.A Award	Director, President and CEO	AAward	+31.3K sh	—	—	269,381
2024-03-11	Harpoon Therapeutics, Inc.D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−269K sh	—	—	0
2024-03-11	Harpoon Therapeutics, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−2,765 sh	—	—	0
2024-01-07	Harpoon Therapeutics, Inc.A Award	Director, President and CEO	AAward	+179K sh	—	—	232,003
2023-11-26	Harpoon Therapeutics, Inc.A Award	Director, President and CEO	AAward	+50K sh	—	—	53,503
2023-05-26	DVAXDYNAVAX TECHNOLOGIES CORPA Award	Director	AAward	+5,357 sh	—	—	10,714
2023-05-26	DVAXDYNAVAX TECHNOLOGIES CORP · Stock Option (Right to Buy)A Award	Director	AAward	+22.5K sh	—	—	22,500
2023-03-23	CALCCalciMedica, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	+1,429 sh	—	—	1,429
2023-03-23	CALCCalciMedica, Inc. · Restricted Stock UnitD Disposition to Issuer	Director	DDisposition to Issuer	−1,429 sh	—	—	0
2023-01-24	Harpoon Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+408K sh	—	—	407,600
2022-06-02	CALCCalciMedica, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2022-06-02	CALCCalciMedica, Inc. · Restricted Stock UnitsA Award	Director	AAward	+20K sh	—	—	20,000
2022-05-26	DVAXDYNAVAX TECHNOLOGIES CORP · Option (Right to Buy)A Award	Director	AAward	+22.5K sh	—	—	22,500
2022-05-26	DVAXDYNAVAX TECHNOLOGIES CORP · Restricted Stock UnitA Award	Director	AAward	+5,357 sh	—	—	5,357
2021-11-08	Harpoon Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+350K sh	—	—	350,000
2021-06-02	CALCCalciMedica, Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2021-05-28	DVAXDYNAVAX TECHNOLOGIES CORP · Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2021-05-04	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+10.2K sh	—	—	10,167
2021-05-04	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+10.2K sh	—	—	10,167
2020-09-24	CALCCalciMedica, Inc. · Director Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2020-07-17	DVAXDYNAVAX TECHNOLOGIES CORP · Stock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2020-05-28	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+10.2K sh	—	—	10,167
2019-06-03	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+10.2K sh	—	—	10,167
2019-02-07	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+5,907 sh	—	—	5,907
2018-03-09	Cascadian Therapeutics, Inc.Restricted Stock UnitsD Disposition to Issuer	CFO & CBO	DDisposition to Issuer	−11.3K sh	—	—	0
2018-03-09	Cascadian Therapeutics, Inc.Restricted Stock UnitsD Disposition to Issuer	CFO & CBO	DDisposition to Issuer	−16.5K sh	—	—	0
2018-03-09	Cascadian Therapeutics, Inc.Restricted Stock UnitsD Disposition to Issuer	CFO & CBO	DDisposition to Issuer	−199K sh	—	—	0
2018-03-09	Cascadian Therapeutics, Inc.Stock Option (Right to buy)D Disposition to Issuer	CFO & CBO	DDisposition to Issuer	−8,334 sh	—	—	0
2018-03-09	Cascadian Therapeutics, Inc.Stock Option (Right to buy)D Disposition to Issuer	CFO & CBO	DDisposition to Issuer	−8,334 sh	—	—	0
2018-03-09	Cascadian Therapeutics, Inc.Stock Option (Right to buy)D Disposition to Issuer	CFO & CBO	DDisposition to Issuer	−8,334 sh	—	—	0
2018-03-09	Cascadian Therapeutics, Inc.Stock Option (Right to buy)D Disposition to Issuer	CFO & CBO	DDisposition to Issuer	−6,667 sh	—	—	0
2018-03-09	Cascadian Therapeutics, Inc.Stock Option (Right to buy)D Disposition to Issuer	CFO & CBO	DDisposition to Issuer	−25K sh	—	—	0
2018-03-09	Cascadian Therapeutics, Inc.Stock Option (Right to buy)D Disposition to Issuer	CFO & CBO	DDisposition to Issuer	−16.7K sh	—	—	0
2018-03-09	Cascadian Therapeutics, Inc.Stock Option (Right to buy)D Disposition to Issuer	CFO & CBO	DDisposition to Issuer	−41.7K sh	—	—	0
2018-03-09	Cascadian Therapeutics, Inc.Stock Option (Right to buy)D Disposition to Issuer	CFO & CBO	DDisposition to Issuer	−50K sh	—	—	0

Recent filings

Accepted (ET)
May 184
EASTLAND JULIA MARIE0002064832-26-000203
SEC(opens sec.gov)
Feb 104
EASTLAND JULIA MARIE0001500189-26-000004
SEC(opens sec.gov)
Jan 94
EASTLAND JULIA MARIE0001500189-26-000002
SEC(opens sec.gov)
May 164
EASTLAND JULIA MARIE0001062993-25-009692
SEC(opens sec.gov)
Feb 54
EASTLAND JULIA MARIE0001725160-25-000036
SEC(opens sec.gov)
Feb 44
EASTLAND JULIA MARIE0001725160-25-000028
SEC(opens sec.gov)
Dec 34
EASTLAND JULIA MARIE0001725160-24-000189
SEC(opens sec.gov)
Sep 124
EASTLAND JULIA MARIE0001062993-24-016538
SEC(opens sec.gov)
May 284
EASTLAND JULIA MARIE0000950170-24-065588
SEC(opens sec.gov)
Mar 114
EASTLAND JULIA MARIE0000950170-24-029430
SEC(opens sec.gov)
Jan 94
EASTLAND JULIA MARIE0000950170-24-003365
SEC(opens sec.gov)
Nov 284
EASTLAND JULIA MARIE0001209191-23-056805
SEC(opens sec.gov)

Companies

Address

C/O LANTHEUS HOLDINGS, INC. 201 BURLINGTON ROAD, SOUTH BUILDING

BEDFORD, MA, 01730